Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
20% trichloroacetic acid vs topical steroid + tretinoin in macular amyloidosis
IRCT20180102038188N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of trichloroacetic acid and tretinoin in Macular Amyloidosis (2 arms), sponsored by Sabzevar University of Medical Sciences. Started Jun 2018; status: completed.
02
Drugs
trichloroacetic acidtretinoin
03
Conditions
Macular Amyloidosis
Beyond the preview
Go deeper on IRCT20180102038188N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180102038188N1.